Categories: All postsListed

Amazon to sell One Medical benefits to Prime members

Today’s health-related news from Amazon (Amazon Stock Quote, Chart, News, Analysts, Financials Nasdaq:AMZN) includes the introduction of a new health care benefit for Prime members. This benefit allows Prime members to access One Medical health care for a monthly fee of $9 or an annual fee of $99, providing a significant discount off the standard membership fee. Additionally, Prime members can extend this benefit to up to five additional family members at reduced rates​​.

Moreover, Amazon Clinic, which offers care for over 35 common health concerns such as asthma, eczema, acid reflux, and pinkeye, is now available in all 50 states and Washington, D.C. This service provides greater access to licensed clinicians for virtual care, particularly beneficial for those without health insurance​​​​.

Amazon has also partnered with One Medical to deliver primary care that is tailored to individual needs, with most major insurance plans being accepted. Prime members have the added benefit of getting eligible medications for a flat rate of $5 a month​​.

While these developments mark significant progress in Amazon’s health operation, the company’s executives acknowledge that it is still years away from being a major disruptor in the vast $4 trillion health care industry​​.

Amazon announced its plans to acquire One Medical, a telehealth and primary care service provider, on July 21st, and the acquisition deal was valued at approximately $3.9 billion.

Tagged with: amzn
ChatGPT

ChatGPT is a large language model developed by OpenAI, based on the GPT-3.5 architecture. It was trained on a massive amount of text data, allowing it to generate human-like responses to a wide variety of prompts and questions. ChatGPT can understand and respond to natural language, making it a valuable tool for tasks such as language translation, content creation, and customer service. While ChatGPT is not a sentient being and does not possess consciousness, its sophisticated algorithms allow it to generate text that is often indistinguishable from that of a human.

Recent Posts

Hut 8 stock: Buy, Sell or Hold?

Roth Capital Partners analyst Bryan Baratian maintained his “Buy” rating and US$108.00 target on Hut 8 (Hut 8 Stock Quote,… [Read More]

8 hours ago

This investor explains why he loves Topicus stock

Baskin Wealth Management president and chief investment officer Barry Schwartz named Topicus.com (Topicus.com Stock Quote, Chart, News, Analysts, Financials TSX:TOI)… [Read More]

8 hours ago

RNA stock: time to buy?

On Oct. 29 Roth Capital Partners analyst Boobalan Pachaiyappan maintained his “Buy” rating and US$15.00 target on Atrium Therapeutics (Atrium… [Read More]

8 hours ago

TD raises price target on Coveo Solutions

TD Cowen analyst David Kwan raised his target on Coveo Solutions (Coveo Solutions Stock Quote, Chart, News, Analysts, Financials TSX:CVO)… [Read More]

12 hours ago

Electrovaya has an upside of 143%, this analyst says

Roth Capital Partners analyst Craig Irwin maintained his “Buy” rating and US$14.00 target on Electrovaya (Electrovaya Stock Quote, Chart, News,… [Read More]

13 hours ago

Analyst raises his price target on Kinaxis to $225.00

Stifel analyst Suthan Sukumar raised his target on Kinaxis (Kinaxis Stock Quote, Chart, News, Analysts, Financials:TSX:KXS) to $225.00 from $200.00,… [Read More]

14 hours ago